MST1/Hippo Promoter Gene Methylation Predicts Poor Survival in Patients With Malignant Pleural Mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 Trial
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0379-8
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Springer Science and Business Media LLC